Clinical Trials & Research
Many of today's most effective standard treatments are based on the results of previous clinical studies, and many cancer patients are now living longer because of progress made through clinical trials. Clinical trials offer high quality cancer care and also allow patients the opportunity to advance scientific knowledge and help future patients.
Ongoing research is essential in the fight against cancer, and it is one of the major objectives of the Edwards Comprehensive Cancer Center.
Clinical trials currently available
| Code | Description |
|---|---|
| CALGB-90203 | A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer. |
| CALGB-C90601 | A Randomized Double-Blinded Phase III Study comparing Gemcitabine, Cisplatin and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma. |
| S0931 | Renal Cell (GU)- EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study. |
- Page last updated: Jan 4, 2013
-
